ExonanoRNA, LLC was established in 2017 to fill a market gap for the commercial production of high-quality RNA nanoparticles for research and pre-clinical development. RNA nanotechnology allows the integration of multiple functional RNA modules into one nanoparticle, of which the scaffold, ligand, therapeutic moieties, and regulator can be composed predominantly or exclusively of RNA. Our core activities include research and develop of a broad range of innovative products in the primary area of RNA nanotechnology-based platforms for next generation targeted drug delivery and disease diagnosis. Our team is comprised of experienced scientists that efficiently coordinate a multidisciplinary effort to transition bio-nanotechnology, especially RNA nanotechnology from the bench to the clinic.
Company Details
- Employees
- 6
- Founded
- 2017
- Address
- 1275 Kinnear Rd, Columbus,ohio 43212,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- exonanorna.com
- Keywords
- oligonucleotide synthesis, RNA nanotechnology, nucleic acid therapeutics, modified oligomers.
- HQ
- Columbus, Ohio
Exonanorna Questions
Exonanorna's website is exonanorna.com
Exonanorna's LinkedIn profile is https://www.linkedin.com/company/exonanorna
Exonanorna has
6 employees.
View email and phone details for 6
employees at Exonanorna.
Exonanorna's industry is
Biotechnology Research
Exonanorna's top competitors are
Sarepta Therapeutics,
Nantucket Spider & Nantucket Footprint,
Quivivepharma Inc,
Andelyn Biosciences,
Battelle,
Kimball Midwest,
Forge Biologics,
Guild Biosciences,
3barbio,
Columbus Nanoworks, Inc..
Exonanorna's categories are Biotechnology Research
Exonanorna's founding year is 2017
